Steven Previsich Apoc in Anaheim, CA - Clinic/Center

Steven Previsich Apoc is a Clinic/center based in Anaheim, California. Steven Previsich Apoc is licensed to practice in * (Not Available) (license number ) and their current practice location is 2137 E Lincoln Ave, Anaheim, California. It can be reached at their office (for appointments etc.) via phone at (251) 401-2096.

NPI number for Steven Previsich Apoc is 1518733567 and their current mailing address is 2137 E Lincoln Ave, Anaheim, California. Steven Previsich Apoc does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1518733567.

Contact Information

	Steven Previsich Apoc
	2137 E Lincoln Ave, Anaheim, CA 92806-4106
	(251) 401-2096
	(714) 999-1439

Healthcare Provider's Profile

Full Name	Steven Previsich Apoc
Type	Facility
Speciality	Clinic/center
Location	2137 E Lincoln Ave, Anaheim, California
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1518733567
Provider Enumeration Date: 11/30/2023
Last Update Date: 11/30/2023

Medical Identifiers

Medical identifiers for Steven Previsich Apoc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518733567	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Secondary
261Q00000X	Clinic/center	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steven Previsich Apoc is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Steven Previsich Apoc 2137 E Lincoln Ave, Anaheim, CA 92806-4106 Ph: (251) 401-2096	Steven Previsich Apoc 2137 E Lincoln Ave, Anaheim, CA 92806-4106 Ph: (251) 401-2096

News Archive

GSK and Prosensa commence GSK2402968 Phase III study in DMD

GlaxoSmithKline and Prosensa today announced that the first patient has commenced treatment in the Phase III clinical study investigating GSK2402968, in ambulant boys with Duchenne Muscular Dystrophy (DMD), who have a dystrophin gene mutation amenable to an exon 51 skip (up to 13% of boys with DMD). Commencement of this study confirms previously announced plans to progress this asset into Phase III.

Nivolumab and pembrolizumab therapies continue to show promise against advanced melanomas

Results of two clinical trials reported at the American Society for Clinical Oncology Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. Dr. Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, is an author of both studies.

Tel Aviv University joins volunteer initiative to improve detection of novel coronavirus in Israel

Israeli hospitals and universities, including Tel Aviv University, have joined forces to build an enormous student volunteer base to expand and improve the detection of people infected with novel coronavirus all over Israel.

Lack of adequate sleep can interfere with fundamental cellular process

Lack of adequate sleep can do more than just make you tired. It can short-circuit your system and interfere with a fundamental cellular process that drives physical growth, physiological adaptation and even brain activity, according to a new study from the University of Tennessee, Knoxville.

Steven Previsich Apoc - in Anaheim, CA